News Focus
News Focus
Followers 0
Posts 12
Boards Moderated 0
Alias Born 10/30/2015

Re: None

Friday, 10/30/2015 9:32:32 AM

Friday, October 30, 2015 9:32:32 AM

Post# of 595
Teikoku Pharma USA And Eagle Pharmaceuticals (EGRX) Enter Into License Agreement For Docetaxel, Non-Alcohol Formula

SAN JOSE, Calif., Oct. 15, 2015 /PRNewswire/ -- Teikoku Pharma USA Inc. ("TPU") today announced that it has entered into an exclusive license agreement with Eagle Pharmaceuticals, Inc. to market, sell, and distribute TPU's Docetaxel Injection, Non-Alcohol Formula in the United States. Once approved by the U.S. Food and Drug Administration ("FDA"), Docetaxel Injection has the potential to be the first docetaxel alcohol-free formulation approved in the US.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y